Creatinine Test Market: Information by Test Type (Blood Test, Urine Test and Creatinine Clearance Test), Product Type (Consumables and Instruments), Application (Urinary Tract Obstruction, Renal Failure, Kidney Cancer and Glomerulonephritis), End User (Hospital and Clinics, Diagnostic Centre and Research Institutes) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2030

Creatinine Test Market Overview

The global creatinine test market size is expected to reach USD 2.5 Billion million by 2030 and projected to grow at a compound annual growth rate of 15.8% between 2022 and 2030. An increasing number of people suffering from renal diseases is likely to fuel the market's revenue growth in the coming years. Growing elderly populations, medical technology advances, and government spending on healthcare to combat the development of renal disorders are all contributing to the market's revenue growth.

Kidney-related illnesses have increased rapidly in recent years, necessitating different renal therapies. Patients with renal problems must constantly monitor their urine creatinine and albumin levels and ratios. When it comes to kidney disease diagnosis and treatment, many urine testing practices and techniques are being used. It is also possible to do biochemical urine analysis, which measures the concentration of chemical substances in the urine. Abnormally high levels of such substances may indicate abrupt kidney injury or kidney problems. As a result, the Creatinine Test Market outlook is expected to grow rapidly over the next several years.

This report contains all the information on the global creatinine test market analysis and the market strengths. In addition, the report also includes the culmination of dynamics, segmentation, key players, regional analysis, and other essential factors. And a detailed analysis of the global creatinine test market forecast for 2030 is also included in the report.

Creatinine Test Market Covid 19 Analysis

The emergence of COVID-19 has impacted a broad range of sectors throughout the globe. Governments have adopted pandemic control measures throughout the globe to slow the spread of the disease as quickly as possible. During the early phases of the pandemic, industrial facilities all around the globe were forced to shut down their operations. As a result, a major lag in the commercial launch of the electronics sector might result from the subsequent financial downturn.

Creatinine Test Market Dynamic

Drivers

The creatinine testing market’s methods and processes is growing due to increased demand. The desire for quick creatinine testing techniques is being driven by the increased frequency of diabetes and the rising prevalence of kidney cancer patients, glomerulonephritis, and renal failures, among other conditions that severely impact kidneys. An organic residual waste known as creatinine is created by the degradation of the oxalic compound known as creatine, abundant in muscle tissue. Clinical labs employ creatinine in GFR and BUN tests to assess a patient's overall health and renal function.

Opportunities

This market will continue to develop as the world's aging population increases the risk of chronic kidney disease. Government policies to encourage kidney health are also helping to push the industry forward, as are new monitoring techniques and technological advancements in the kidney function testing. Rapid creatinine measurement devices at the point of care are one such potential technical innovation. This helps to eliminate the need for highly skilled analytical experts to carry out complex monitoring procedures.

Restraints

Creatinine measurement methods lack predictive ability, and health providers' changing priorities toward innovative approaches, such as the discovery of renal failure biomarkers, are projected to restrain market expansion.

Challenges

Companies of all sizes, from micro-startups to large multinationals, rely heavily on small and medium-sized businesses for the majority of their income. Industry actors were confronted with several issues in light of supply chain interruptions. Things are expected to become better in the 2nd half of the year 2022 due to more supply coming online.

Cumulative Growth Analysis

Creatinine testing is a major industry in the United States. According to industry analysts, creatinine testing sales in the United States are expected to remain dominant in the worldwide market through 2022-2030. The creatinine test market share in the United States has grown rapidly in recent years, and it is expected to dominate the North American market over the projected period. The growing elderly populations in the United States and Canada pose a greater risk of developing diabetes, pressure, and consequent renal illnesses such as acute kidney illnesses and renal failure. This demographic shift is expected to increase the need for creatinine testing in both countries.

Value Chain Analysis

The creatinine test market has been divided into test types, product types, applications, and end-users. The market has been divided into three sections based on blood tests, urine tests, and creatinine tests. Commodities and instruments make up the bulk of the industry. Reproductive tract obstruction, renal failure, and glomerulonephritis make up different market segments for these drugs. Hospitals and clinics, diagnostic centers, and research institutions make up the majority of the market.

Because of improved hospital infrastructure, increased accessibility, and an abundance of modern diagnostic services and highly trained medical staff, hospitals and clinics will have a commanding revenue share in worldwide markets by 2020. By 2020, blood tests are expected to have the greatest share of the worldwide market in terms of revenue. Rapid and easy blood testing procedures are fueling this segment's sales development.

Creatinine Test Market Segmentation Overview

The market is segmented based on test types, product types, applications, and end-users. As a result, global creatinine test market trends are expected to witness decent growth during the forecast period.

By Application

The market is segmented into Urinary Tract Obstruction, Renal Failure, Kidney Cancer, and Glomerulonephritis.

By end-users

The market is segmented into hospitals & Clinics, Diagnostic Centers, and Research Institutes based on the propulsion types.

Creatinine Test Market Regional Analysis

The global creatinine tests market has been segmented into the following four groups: the Americas, Europe, Asia-Pacific, and the Middle East and Africa. 

The creatinine test industry is forecast to be dominated by the Americas during the projected period. This may be linked to an increase in the number of renal disorders, improved technology, higher costs of healthcare, and the existence of major competitors in the industry. Europe is the 2nd largest market for creatinine after the United States. Increasing government backing, growing healthcare costs, and advanced technology contribute to the market's growth.

Since there is a large patient population in Asia-Pacific, early diagnosis is becoming more important and technological advancements. The administration's efforts to combat kidney problems are also helping to fuel the market's expansion. In 2016, China had a 22.6% share of the global market. There are many impoverished and slow-developing nations in the Middle East and Africa area, which is projected to limit the industry's share in the Middle East & Africa.

Competitive landscape

Agreements, new product introductions, and mergers, amongst other techniques, are some of the most prominent methods these companies are using to extend their influence in the worldwide market. They are developing kits and reagents for creatinine detection and new methods for detecting the molecule.

Major Key Players

• BioAssay Systems


• Abcam PLC


• Arbor Assays


• Randox Laboratories Ltd


• DiaSys Diagnostic Systems GmbH


• MedTest Holdings, Inc. (Pointe Scientific, Inc.)

Report Overview

• The following report comprises of –


• Market overview 


• Covid 19 Analysis


• Market Dynamic


• Drivers


• Opportunities


• Restraints 


• Challenges


• Cumulative Growth Analysis


• Value Chain Analysis


• Segmentation Overview 


• By Application 


• By End-Users


• Regional Analysis


• Competitive landscape

Recent Developments

• In December of 2018, Siemens Healthineers and Healthy.io came together to form a partnership that will assist in increasing the availability to albumin-to-creatinine ratio testing and will make it simpler for patients to adhere with chronic kidney disease monitoring.


• Siemens Healthineers gained FDA clearance in February 2018 for its point-of-care BUN and TCO2 tests to assist in the identification of renal disorders and metabolic abnormalities. These tests measure blood urea total co2 and nitrogen.

Market Segmentation

• Creatinine Test Market, by Test Type

Blood Test

Urine Test

Creatinine Clearance Test

• Creatinine Test Market, by Product Type

Consumables

Instruments

• Creatinine Test Market, by Application

Urinary Tract Obstruction

Renal Failure

Kidney Cancer

Glomerulonephritis

• Creatinine Test Market, by End User

Hospital & Clinics

Diagnostic Centre

Research Institutes

• Creatinine Test Market, by Region


• Americas

North America

US

Canada

South America

• Europe

Western Europe

Germany

UK

Italy

Spain

Rest of Western Europe

Eastern Europe

• Asia-Pacific

China

Japan

India

Australia

Republic of Korea

• Rest of Asia-Pacific


• Middle East & Africa

Middle East

Africa